Naser Farrokhi | Plant Cell Biology | Best Researcher Award

Published on 08/08/202508/08/2025 by Cell Biologist

Assoc. Prof. Dr. Naser Farrokhi | Plant Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Naser Farrokhi | Shahid Beheshti University | Iran

Dr. Naser Farrokhi is an accomplished Associate Professor in the Department of Cell & Molecular Biology at Shahid Beheshti University, Tehran, Iran. With a Ph.D. in Plant Molecular Biology from the University of Adelaide, his expertise lies in plant genomics, particularly in functional gene analysis for crop improvement. Over two decades, he has led impactful research projects focusing on rice genomics, plant peptides, cell wall biosynthesis, and nanotechnology in agriculture. His work bridges cutting-edge molecular biology with practical breeding strategies, aiming to develop ideotype rice varieties adapted to future environmental demands. Dr. Farrokhi has received prestigious national and international scholarships and has published extensively in high-impact journals. He collaborates globally across disciplines, contributing to sustainability, biotechnology, and agricultural resilience. His multidisciplinary approach has also explored biomedical applications of plant-derived materials. With a strong teaching and mentorship record, Dr. Farrokhi exemplifies innovation, leadership, and scientific rigor in plant science and biotechnology.

Publication Profile:

Google Scholar

Scopus

Orcid

Education:

Dr. Naser Farrokhi holds a Ph.D. in Plant Molecular Biology from the University of Adelaide, where he studied the functional analysis of barley glycosyltransferases under the supervision of Prof. Dr. Geoffrey Bruce Fincher. He earned his M.Sc. in Plant Breeding from Azad University, Karaj, Iran, with a thesis on genotypic and phenotypic variation of quantitative traits in mungbean, guided by Prof. Dr. Alireza Taleie. His academic journey has been supported by competitive scholarships from Iran’s Ministry of Science and the Agricultural Research, Education and Extension Organization (AREEO). These solid academic foundations in plant breeding and molecular biology have enabled Dr. Farrokhi to integrate classical breeding approaches with modern genomics. His academic training across continents has equipped him with advanced technical skills, a global research perspective, and the capacity to lead in interdisciplinary collaborations focused on crop improvement and plant biotechnology.

Experience:

Dr. Farrokhi has over 20 years of experience in plant molecular biology and functional genomics. Currently an Associate Professor at Shahid Beheshti University, he teaches and supervises graduate students in plant biotechnology, cell biology, and molecular breeding. His postdoctoral research at California State University, Long Beach, focused on gene function in plant systems using transcriptomic approaches. He has worked extensively with GWAS, CRISPR genome editing, and bioinformatics for trait dissection in rice and other crops. His leadership in multi-institutional projects has contributed to advancements in crop biofortification, stress tolerance, and sustainability. He is also involved in translational research, such as nanomaterials in regenerative medicine and environmental applications. His career is marked by collaborative, cross-disciplinary work and a strong publication record. Dr. Farrokhi has served as a peer reviewer, scientific advisor, and mentor, demonstrating commitment to both research and academic excellence across national and international platforms.

Awards & Honors:

Dr. Naser Farrokhi has been the recipient of several prestigious awards throughout his academic and research career. he earned a scholarship from the Agricultural Research, Education and Extension Organization (AREEO) of Iran to pursue his M.Sc., he was awarded a Ph.D. scholarship by the Ministry of Science, Research, and Technology of Iran to study in Australia. His postdoctoral research in the United States was supported by the National Science Foundation Fellowship at California State University Long Beach in 2005. These accolades highlight his consistent academic excellence and potential for innovative research. He is frequently invited to collaborate in national and international projects due to his proven expertise in plant genomics, biotechnology, and sustainable agriculture. His track record of publications and contributions to interdisciplinary research have earned him recognition in plant sciences, biotechnology, and even biomedical fields.

Research Focus:

Dr. Farrokhi’s research is centered on plant molecular biology, functional genomics, and crop improvement, with a major focus on rice as a model and target crop. He employs genome-wide association studies (GWAS), transcriptomics, and post-GWAS analysis to identify key genes involved in vitamin E biosynthesis, yield-related traits, and stress responses. His goal is to develop future-ready rice ideotypes using conventional breeding or genome editing. His research extends to safflower developmental biology, cannabis-derived materials for biomedical applications, and nanotechnology-based agricultural inputs. He integrates bioinformatics, co-expression network analyses, and proteomics to dissect gene regulatory pathways. His collaborative work across plant and animal systems has also explored osteoinduction, tissue regeneration, and nanoscience applications. Dr. Farrokhi’s research is impactful, interdisciplinary, and focused on sustainability, nutrition, and climate resilience, positioning him at the forefront of innovative agricultural biotechnology.

Publications Top Notes:

Comparative transcriptome analysis of multi-branched safflower mutant vs. WT
Unraveling molecular mechanisms of phytohormonal regulation in safflower buds
Enhanced osteoinduction using porous herbal cellulose nanostructures
Interplay of rice vitamin E under abiotic stresses via in-silico transcriptomics
rGO-coated cannabis-derived nanogrooved scaffolds for bone regeneration
Recent advances on GLA-producing organisms – future biotechnological directions
Post-GWAS analysis of tocopherol content in rice seeds
GWAS-based dissection of yield components in rice (Oryza sativa L.)
Gene expression in coral bleaching under high temperature stress
Co-expression network of microproteins in plant embryo development

Conclusion:

Dr. Farrokhi’s robust publication record, innovative research in rice genomics, and commitment to academic excellence make him a highly suitable candidate for the Best Researcher Award. His work contributes meaningfully to addressing current and future challenges in sustainable agriculture and plant biotechnology.

Pryanka Thakur | Dengue | Young Scientist Award

Published on 02/08/202502/08/2025 by Cell Biologist

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile:

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes:

Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe – Infection, 2022.
Viral Hepatitis E and Chronicity: A growing public health concern – Frontiers in Microbiology, 2020.
Monkeypox virus in humans: A concern – Trespassing global boundaries – Int J Surg, 2022.
Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabets – Int J Surg, 2022.
Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika? – Brain Behav Immun, 2021.
Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a year – Immunome Research, 2021.
Avian influenza revisited: Concerns and constraints – VirusDisease, 2022.
Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnancies – Eur J Obstet Gynecol Reprod Biol, 2023.
Post-COVID-19 era: Re-emergence of known and future (X) viral pathogens – Vacunas, 2024.
Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp. – 3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Published on 02/08/202502/08/2025 by Cell Biologist

Dr. Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Shuxin Han | Xinjiang University | China

Dr. Shuxin Han is a distinguished molecular biologist and professor at Xinjiang University, widely recognized for his pioneering work in hepatobiliary and metabolic biology. With a research career spanning over two decades, Dr. Han has made major contributions to understanding how Kruppel-like factors, especially KLF15, regulate endobiotic and xenobiotic metabolism, impacting drug detoxification and metabolic disease mechanisms. He earned his Ph.D. from Kent State University and has held prestigious positions at Harvard Medical School and Case Western Reserve University. His groundbreaking studies have been published in high-impact journals like Nature Metabolism and Nature Communications, with several articles naming him as first or corresponding author. In addition to research, Dr. Han serves as a reviewer for top-tier journals in pharmacology, hepatology, and clinical science. He is also an academic leader, currently shaping the next generation of scientific talent and metabolic disease research in China.

Publication Profile:

Scopus

Education:

Dr. Shuxin Han began his academic journey in Animal Sciences, earning a bachelor’s degree from Anhui Agricultural University (1994–1998). He advanced to a research assistant role at Peking University (1999–2000), where he deepened his scientific foundation. He then moved to the U.S. to pursue a Master’s in Biology at Temple University (2000–2003), followed by a Ph.D. in Molecular Biology from Kent State University (2004–2009), focusing on metabolic biology and gene regulation. This progression from general animal sciences to highly specialized molecular biology reflects a systematic and deep commitment to biomedical research. His strong academic preparation laid the foundation for a research career investigating how transcriptional regulators impact health and disease. Dr. Han’s training spans world-class institutions across both China and the United States, equipping him with diverse scientific perspectives and techniques.

Experience:

Dr. Shuxin Han has accumulated rich research and academic experience over nearly 30 years. His early career included a pivotal research assistant role at Peking University, followed by advanced training in biology and molecular biology at Temple and Kent State Universities. He completed prestigious postdoctoral training at Harvard Medical School (2009–2012) and Case Western Reserve University (2012–2015), where he later became a Senior Research Associate (2015–2019). He returned to China in 2019 as a Researcher at the University of Science and Technology of China First Affiliated Hospital, simultaneously engaging in academic duties at the university until 2023. Currently, he serves as a Professor and Academic Leader at Xinjiang University. Throughout his career, Dr. Han has built strong international collaborations, led research groups, and guided innovative projects in metabolic biology, demonstrating his leadership, research excellence, and academic mentorship capabilities.

Research Focus:

Dr. Shuxin Han’s research centers on the molecular regulation of metabolism, particularly focusing on the hepatobiliary and gastrointestinal systems. His work has elucidated the critical role of the Kruppel-like factor (KLF) family, especially KLF15, in controlling endobiotic and xenobiotic metabolism (EXM). These pathways govern how the body metabolizes both internal compounds and external substances like drugs. Dr. Han’s studies have shown that KLF15 acts as a master regulator, influencing drug resistance, liver injury, and metabolic homeostasis. His discoveries offer new insight into personalized medicine and treatment for metabolic disorders and drug-related toxicities. With numerous first-author and corresponding-author publications in journals such as Nature Metabolism, Nature Communications, and Drug Metabolism and Disposition, his work has significantly impacted both fundamental science and clinical applications. He is also active in peer-reviewing for top-tier journals and is recognized for his leadership in translational research.

Publications Top Notes:

Unveiling KLF15 as the Key Regulator of Cyclosporine A Metabolism and Adverse Effects – Drug Metabolism and Disposition, 2025
Distribution and Functional Significance of KLF15 in Mouse Cerebellum – Molecular Brain, 2025
Personalized Statin Therapy: Targeting Metabolic Processes – Heliyon, 2025
Current Status and New Directions for Hepatocellular Carcinoma Diagnosis – Liver Research, 2024
KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury – Drug Metabolism and Disposition, 2024
Advancing Drug Delivery and Bioengineering in Liver Research – Bioengineering and Translational Medicine, 2024
Advances in IL-7 Research on Tumor Therapy – Pharmaceuticals, 2024 (Co-author)
Pathogenic Mechanisms in Alcoholic Liver Disease – Journal of Translational Medicine, 2023
Beta-Hydroxybutyrate Effects on iPSC-Derived Cardiac Myocytes – Biomolecules, 2022
Interactions Between Intestinal Flora and Bile Acids – International Journal of Molecular Sciences, 2022 (Corresponding author)

Conclusion:

In conclusion, Dr. Shuxin Han is a highly deserving candidate for the Best Researcher Award. His pioneering work on KLF15 and metabolic regulation has reshaped fundamental understanding in the field of hepatobiliary biology and pharmacology. His academic background, research productivity, international experience, and editorial service all reflect a well-rounded and impactful scientist. While there is room to increase clinical translation and international engagement, the depth, originality, and consistency of his research make him a strong contender for this recognition. Honoring Dr. Han with this award would acknowledge a career dedicated to scientific advancement with substantial implications for human health and drug therapy.

Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Published on 02/08/202502/08/2025 by Cell Biologist

Dr. Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Dr. Kai Zhao | shandong first medical university | China

Kai Zhao is a dedicated biomedical scientist specializing in cell biology and translational medical research. Affiliated with the Central Hospital and Shandong First Medical University, Kai has focused on molecular mechanisms underlying diseases such as osteosarcoma and neurodegeneration. Their expertise includes mitophagy regulation, exosomal gene biomarkers, and multi-omics analyses, aiming to discover novel therapeutic targets. Kai has contributed significantly to understanding how cellular degradation pathways influence disease progression, with published work in prominent journals. They hold key roles in both clinical and research settings, bridging basic science and patient care. Their collaborative work and innovative approach have garnered attention in the biomedical community, underscoring their role as a rising leader in cell biology research.

Publication Profile:

Orcid

Education:

Kai Zhao completed their foundational studies in medicine at a prestigious medical university in China, followed by advanced graduate training focusing on cellular and molecular biology. Their education provided a strong grounding in clinical medicine combined with rigorous laboratory research skills. They further specialized through postgraduate work that integrated molecular biology techniques and omics technologies, developing expertise in the mechanisms of disease at a cellular level. This multidisciplinary education enabled Kai to pursue research at the interface of clinical practice and experimental biology. They have also completed specialized training in bone biomechanics and metabolism, as well as spinal surgery, enhancing their ability to conduct translational research. Continuous professional development through workshops, conferences, and collaborative projects complements their formal education, keeping them updated on cutting-edge scientific advances.

Experience:

Kai Zhao has extensive experience working at the Central Hospital Affiliated with Shandong First Medical University, where they contribute both clinically and in research. Their experience includes investigating molecular pathways in osteosarcoma and neurodegenerative models using cell lines such as SH-SY5Y. Kai has led projects applying multi-omics data to identify exosomal gene biomarkers and therapeutic targets like mifepristone. Their role in the Spinal Surgery Department and Bone Biomechanics Laboratory has provided hands-on clinical insight, informing their research on bone and spinal disorders. Kai collaborates with multidisciplinary teams, combining clinical knowledge with molecular techniques. Their publication record reflects proficiency in advanced methodologies such as mitophagy analysis, molecular degradation pathways, and biomarker discovery. Kai also mentors junior researchers and participates in academic dissemination through publications and conferences, demonstrating leadership and a commitment to advancing cell biology research.

Research Focus:

Kai Zhao’s research centers on the molecular and cellular mechanisms driving disease, with an emphasis on mitophagy, exosomal biomarkers, and multi-omics analyses. They investigate how cellular quality control systems, such as the PINK1-mediated mitophagy pathway, contribute to neurodegenerative diseases and cancer progression, specifically osteosarcoma. By combining genomic, proteomic, and transcriptomic data, Kai aims to identify novel gene biomarkers within exosomes that can serve as diagnostic or therapeutic targets. One highlighted therapeutic candidate from their work is mifepristone, revealed through integrative multi-omics to be effective against osteosarcoma. Their research integrates cellular biology with clinical insights, particularly in bone metabolism and spinal diseases, aiming for translational impact. Overall, Kai’s focus is on uncovering how disruptions in cellular degradation and intercellular communication contribute to disease, leveraging multi-disciplinary approaches to develop targeted therapies.

Publication Top Notes:

- Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi‐Omics Analysis
- IRGM promotes the PINK1-mediated mitophagy through the degradation of Mitofilin in SH-SY5Y cells

Conclusion:

Kai Zhao is a promising and capable researcher whose work directly contributes to cutting-edge cell biology, particularly in disease mechanisms. Their multi-omics and cellular degradation studies mark them as an excellent candidate for the Cell Biology Research Award.

Leandro Rodriguez-Viera | Molecular Mechanisms Signaling | Best Researcher Award

Published on 01/08/202501/08/2025 by Cell Biologist

Dr. Leandro Rodriguez-Viera | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Leandro Rodriguez-Viera | Universisdad de Cadiz | Spain

Dr. Leandro Rodríguez Viera is a marine biologist with dual Ph.D. degrees from the University of Havana (Cuba) and the University of Cádiz (Spain), specializing in digestive physiology and trophic ecology of marine organisms. With over 15 years of experience in biological and aquaculture research, he has significantly contributed to the understanding of nutrient metabolism and predation dynamics in marine ecosystems. His scientific trajectory is defined by interdisciplinary work combining enzymology, nutrition, and biodiversity. Dr. Rodríguez Viera has published extensively in high-impact journals and collaborates with research teams across Europe, Latin America, and the Caribbean. He is also a co-recipient of the prestigious Cuban Academy of Sciences National Prize. His dedication to marine biology is evident through his active role in identifying invasive species and documenting marine biodiversity. His contributions enhance conservation efforts, sustainable aquaculture, and the ecological management of tropical marine environments.

Publication Profile:

Google Scholar

Scopus

Orcid

Education:

Dr. Leandro Rodríguez Viera’s educational journey began with a Bachelor in Biology from the University of Havana in 2008, followed by a Master’s degree in Marine Biology and Aquaculture in 2010 from the same institution. He earned a Ph.D. in Biological Sciences from the University of Havana in 2018, with research focused on digestive enzymology and metabolism in crustaceans. In parallel, he completed a second Ph.D., Cum Laude, from the University of Cádiz in Spain in 2017, strengthening his expertise in marine physiology and aquaculture. His academic training combines a strong foundation in molecular biology, comparative physiology, and aquatic animal nutrition, positioning him as a multidisciplinary expert in marine life sciences. This robust educational background underpins his successful career in scientific research and publications in diverse fields such as marine biodiversity, gelatinous zooplankton, and digestive physiology in aquatic species.

Experience:

Dr. Rodríguez Viera has over 15 years of research experience in marine biology, aquaculture, and marine ecology. He began his career focusing on the digestive physiology of the spiny lobster (Panulirus argus), contributing to fundamental knowledge and diet development for aquaculture. His career spans collaborative projects with institutions like the University of Cádiz, ICMAN-CSIC, and international teams across Europe and the Caribbean. Dr. Rodríguez Viera has led or co-led several projects on nutrient digestion, enzymatic adaptations, and jellyfish–predator interactions. He is an active contributor to taxonomic, ecological, and metabolic studies involving fish, crustaceans, cnidarians, and tunicates. As a prolific author, he has co-authored numerous peer-reviewed articles and guides. His interdisciplinary approach and regional focus on the Caribbean and Atlantic ecosystems make him a key scientific resource in marine trophic ecology, biodiversity documentation, and environmental monitoring programs.

Awards and Honors:

In 2019, Dr. Leandro Rodríguez Viera was honored with the National Prize of the Cuban Academy of Sciences for his contributions to digestive metabolism in the spiny lobster (Panulirus argus), which directly influenced aquaculture diet formulation. This prestigious award recognized his team’s work spanning universities in Cuba, Spain, and research institutes like ICMAN-CSIC. His earlier works also garnered significant academic citations, demonstrating influence in biochemical, nutritional, and ecological fields. Additionally, his publications in PLoS One, Journal of Experimental Biology, Aquaculture, and Marine Biology have earned wide recognition. Dr. Rodríguez Viera’s research continues to be integral to understanding digestive enzyme dynamics, invasive species spread, and marine food web interactions. His multidisciplinary reach, innovative methodologies, and cross-border collaborations underscore his impact, making him a strong candidate for international recognition and research awards.

Research Focus:

Dr. Rodríguez Viera’s research centers on marine trophic ecology, with a special focus on nutritional physiology, digestion, and gelatinous zooplankton interactions. His pioneering studies on Panulirus argus laid the groundwork for aquaculture diets tailored to digestive enzyme profiles. In recent years, he has explored predator–prey relationships among jellyfish, sea anemones, and fish, contributing to the knowledge of underexplored ecological roles in gelatinous food webs. He is also engaged in biodiversity documentation, especially of cnidarians and tunicates in Cuban and Caribbean waters. His integrative approach combines biochemical assays, molecular analysis, ecological fieldwork, and taxonomic identification. His ongoing projects address species invasions, climate-induced bleaching, and nutrient assimilation in marine organisms. This work supports sustainable marine resource use and enhances our understanding of tropical marine ecosystems, biodiversity threats, and aquaculture development.

Publications Top Notes:

One-carbon nutrients and genistein as nutritional programming effectors in juvenile gilthead seabream – Aquaculture (2025)
Diversity of ctenophores from the Cuban Exclusive Economic Zone – Marine Biology Research (2025)
Review of benthic cnidarians as underappreciated gelatinous predators – Marine Biology (2025)
Novel predation of Scyphozoans by sea anemone Condylactis gigantea – Diversity (2025)
First Atlantic record of genus Timoides in Cuban Caribbean waters – Thalassas (2025)
Ichthyofauna of Ensenada de la Siguanea: Guide to common mangrove and seagrass fishes – Rev. Invest. Mar. (2024)
First occurrence of invasive jellyfish Phyllorhiza punctata in the Dominican Republic – Bulletin of Marine Science (2024)
Opportunistic predation on hydromedusae by butterflyfish and crustaceans – Discover Oceans (2024)
Diversity of pelagic tunicates (Appendicularia & Thaliacea) from Cuba: A review – Marine Biodiversity (2024)
Asymmetrical bleaching of upside-down jellyfish Cassiopea in Cuba – Marine Biodiversity (2024)

Conclusion:

In conclusion, Dr. Leandro Rodríguez Viera is highly deserving of the Best Researcher Award based on his significant contributions to marine biology, digestive physiology, and aquaculture. His dual doctoral qualifications, cross-institutional collaborations, and publication impact reflect a strong and sustained commitment to scientific excellence. With a research trajectory that spans fundamental science to applied marine ecology, Dr. Rodríguez Viera exemplifies the qualities of an innovative and impactful researcher. With continued focus on academic leadership and broader outreach, he is well-positioned to further advance scientific frontiers and make lasting contributions to marine science and aquaculture development.

Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on 01/08/202501/08/2025 by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes:

Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022
The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023
Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021
NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020
Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020
WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019
Proteomic identification of APC interaction partners – Mol Cancer Res, 2019
DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018
Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.